Stay updated with breaking news from Osteosarcoma Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
GOSSELIES, Belgium, December 06, 2023--Regulatory News: TheraVet (ISIN: BE0974387194 – ticker: ALVET), a pioneering company in the management of osteoarticular diseases in pets, updates on the Osteosarcoma Program achievements in 2023.
Fast-growing interest in Osteosarcoma Program since official launch end- March 2023 with a 33% increase in participating Centers16 participating Centers in 7 countriesSuccessful participation to the congress of the European Society of Veterinary OncologyGOSSELIES, Belgium--(BUSINESS WIRE)--Regulatory News:TheraVet (...